Total spending on Super Bowl ads has skyrocketed over the years, growing 5 times larger than it was 23 years ago. In addition to the networks, the entertainment and pop culture partners are also benefiting from the high price tag for 30 seconds of airtime. Ryan Schinman, Co-Founder & CEO of Mayflower Entertainment, was with us to share how he connects brands with athletes, celebrities, and influencers.
Schinman is responsible for orchestrating some of the largest endorsement deals ever made between Madison Avenue and Hollywood. He is credited for creating such partnerships as: Matthew McConaughey and Scarlett Johansson with Dolce and Gabbana, Diddy and Usher with Mercedes, and Oprah and DJ Khaled with Weight Watchers. Schinman said the Super Bowl ad that he was involved in that he is most proud of was the Justin Timberlake commercial with Pepsi. He said it made Pepsi "beyond relevant" in the pop culture world.
Super Bowl ads cost around $5 million. Schinman said there's no exact science for measuring the success of a marketing campaign because there are too many variables. Put simply, if brands can improve their visibility and sell more products, it's worth the investment, he added.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
